Logo ofMiddle East Pharmaceutical Industries company(AvalonPharma)
Middle East Pharmaceutical Industries Co. (AvalonPharma)obtained the approval of the Saudi Food and Drug Authority (SFDA) to register new production lines at factory No. 2 in Riyadh. 
The new production lines are for capsules and tablets, in addition to semi-solid materials including creams, ointments, and gels, Avalon Pharma said in a statement to Tadawul.
When fully operational, the new lines will have a manufacturing and production capacity of 270 million tablets and capsules annually, while the production and manufacturing capacity for semi-solid materials will reach 22 million units annually.
The company explained that commercial production on the newly registered production lines will commence upon obtaining approvals from SFDA.
Logo ofMiddle East Pharmaceutical Industries company(AvalonPharma)
Middle East Pharmaceutical Industries Co. (AvalonPharma)obtained the approval of the Saudi Food and Drug Authority (SFDA) to register new production lines at factory No. 2 in Riyadh.
The new production lines are for capsules and tablets, in addition to semi-solid materials including creams, ointments, and gels, Avalon Pharma said in a statement to Tadawul.
When fully operational, the new lines will have a manufacturing and production capacity of 270 million tablets and capsules annually, while the production and manufacturing capacity for semi-solid materials will reach 22 million units annually.
The company explained that commercial production on the newly registered production lines will commence upon obtaining approvals from SFDA.
